Stay updated on INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.

Latest updates to the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page
- CheckyesterdayChange DetectedThe page revision has been updated to v3.5.5, replacing the previous v3.5.4.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, representing a small update to the page's revision metadata.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the underlying study information.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.5.2 has been introduced, replacing the previous v3.5.0.SummaryDifference0.0%

- Check80 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0; this appears to be a minor maintenance/feature update with no changes to study content or user-facing functionality.SummaryDifference0.0%

- Check95 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INTEGA: Ipilimumab & FOLFOX + Nivolumab & Trastuzumab Clinical Trial page.